Printer Friendly
The Free Library
14,505,807 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Drug safety relies on you, the healthcare professional, find and report new serious adverse reactions.


You as a vigilant healthcare practitioner (HCP HCP,
n healthcare provider, a professional who specializes in treating and managing a person's general or specific health needs.
) can make a major contribution to public health by participating in the Food and Drug Administration's (FDA's) Spontaneous spontaneous /spon·ta·ne·ous/ (spon-ta´ne-us)
1. voluntary; instinctive.

2. occurring without external influence.


spontaneous

having no apparent external cause.
 Reporting System. This means you! How can we help ensure a drug is safe once approved by FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
?

An adverse drug reaction adverse drug reaction,
n a detrimental outcome from a drug. Two types of ADRs exist: Type 1 results from dosage mismatch and Type 2 from rare conditions often as a consequence of a small dose. See also risk or sensitive type.
 begins as a clinical problem in a single person or group of individuals.

Until that problem is reported to the sponsor and/or and/or  
conj.
Used to indicate that either or both of the items connected by it are involved.

Usage Note: And/or is widely used in legal and business writing.
 to the FDA, it is hidden and likely unknown to the medical community.

All potential problems with a drug cannot always be found through clinical trials. Only after it is marketed, when the drug is used by diverse patients with a wide spectrum of healthcare concerns, do unforeseen and rarer adverse events show themselves.

FDA and sponsors cannot examine problems they do not know exist. Timely reporting of adverse events is fundamental to the success of the FDA's surveillance program, especially in the case of newly marketed drugs. It is vitally important that HCPs communicate suspected serious, new drug-associated events to the FDA and/or the pharmaceutical sponsor.

You the healthcare practitioners are on the front line and your reports truly make a difference. New safety issues can be discovered, reported and alerts can go out to the entire medical community. It is a simple and obvious way to save many lives!

Sadly most do not report. We need to change that.

We encourage all HCP to post in their facilities the reporting methods for adverse events to the FDA:

Report New Serious Adverse Reactions adverse reactions,
n.pl unfavorable reactions resulting from administration of a local anesthetic; responsible factors include the drug used, concentration, and route of administration.
 to FDA or to drug sponsor: Phone (1-800-FDA-1088), Fax (1-800-FDA-1078), online at https://www.accessdata. fda.gov/scripts/medwatch/ To the sponsor at the phone number in the product label.
COPYRIGHT 2008 Nevada Nurses Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Practice Issues
Publication:Nevada RNformation
Article Type:Brief article
Geographic Code:1USA
Date:Aug 1, 2008
Words:285
Previous Article:CDC alert on adverse effects consuming "Total Body Formula" and "Total Body Mega Formula".(Practice Issues)(Centers for Disease Control and...
Next Article:Hospital adopts color-based dress code.(Practice Issues)(Mary Washington Hospital)(Brief article)
Topics:



Related Articles
The role of FDA approval in drug cases.
Adverse drug reaction reporting and pharmacovigilance of new therapeutic agents.(Editorial)
FDA issues guidance on drug safety communication.(Drug Safety)
Rights, roles and responsibilities of caregivers, industry and government debated.(Adverse event reporting)
FDA has failed to build a new system to track drugs.(Post-market surveillance)
Contraindications and warnings--January 2007.(List)
FDA announces audio broadcasts on emerging drug safety information.(Information technology)
Canada Proposes Amending The Food And Drugs Act And Creating Consumer Product Safety Legislation.
Legislation could be most significant change in drug law since 1962: CDER's Throckmorton.(FDAAA 2007)
Safety report quality depends upon clinical expertise, direct questioning, HCP education.(Drug Safety)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles